Form D · Pharmaceuticals
Invenra Inc.
Madison, WI · CIK 0001539734
Offering snapshot reported Oct 16, 2018 · SEC filing
- Reported sold
- $7.13M Offering amount: $7.13M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 16, 2018 | Initial | $7,127,814 | No comparison | 23 | SEC filing |
| Oct 5, 2017 | Initial | $2,930,060 | No comparison | 25 | SEC filing |
| Jul 20, 2016 | Initial | $3,012,881 | No comparison | 27 | SEC filing |
| Aug 25, 2015 | Initial | $2,000,000 | No comparison | 28 | SEC filing |
| Jan 28, 2015 | Initial | $2,017,640 | No comparison | 25 | SEC filing |
| Feb 20, 2013 | Initial | $3,000,000 | No comparison | 26 | SEC filing |
| Jan 18, 2012 | Initial | $1,200,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-323695
Source: Form D, filed Oct 16, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roland Green | Director, Executive |
| Richard Lesniewski | Director |
| Emile Nuwaysir | Director |
| Stan Rose | Director |
| David Snyder | Director |
| Paul Weiss | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
505 S. Rosa Road Ste. 235
Madison, WI, 53719
Madison, WI, 53719